Clinical conference: Management of rare events following dermal fillers - Focal necrosis and angry red bumps

Dermatologic Surgery

Volumn 32, Issue 3, 2006, Pages 426-434

  Narins, Rhoda S ^a,f   Jewell, Mark ^b   Rubin, Mark ^c   Cohen, Joel ^d   Strobos, Jur ^e  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e Medicis Pharmaceutical Corp   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFLAMMATORY AGENT; CLARITHROMYCIN; FILLER; GLYCERYL TRINITRATE; HYALURONIC ACID; HYALURONIDASE; LEVOFLOXACIN; PREDNISONE; STEROID;

ARTERY OCCLUSION; ARTICLE; BLEEDING; ERYTHEMA; ESTHETICS; HUMAN; HYPERBARIC OXYGEN; HYPERSENSITIVITY; INFECTION; INFLAMMATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SKIN NECROSIS; STAPHYLOCOCCUS INFECTION; TECHNIQUE; THROMBOCYTE ACTIVATION; TISSUE INJURY; TREATMENT FAILURE; TREATMENT OUTCOME; WRINKLE;

DERMATOLOGIC AGENTS; ERYTHEMA; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; NECROSIS; SKIN;

EID: 33645455483     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32086.x     Document Type: Article

References (36)

1. ®. Approved labeling. (accessed on February 22, 2004).
2. ®. Approved labeling. (accessed on February 22, 2004).
3. Verbal communication. Drs. Alastair and Jeanne Carruthers. (December 2004)
4. Klein AW. Tissue augmentation in clinical practice: injectable bovine collagen. New York, NY Marcel Dekker 1998 p. 125 44.
5. Faich GA. Adverse drug reaction surveillance. N Engl J Med 1986 314 1589 92.
6. Ljungstrom KG Renck H Strandberg K. Adverse reactions to dextran in Sweden 1970-1979. Acta Chir Scand 1983 149 253 62.
7. Faich G Strobos J. Sodium ferric gluconate complex in sucrose safer intravenous iron therapy than iron dextran. Am J Kidney Dis 1999 33 464 70.
8. ®: transcript of an advisory committee meeting for the US Food and Drug Administration (November 21, 2003) (Morning Session). (accessed February 22, 2004).
9. ®). Br J Dermatol 2002 146 920 32.
10. ®). Br J Dermatol 2003 148 379 80.
11. Friedman PM Mafong EA Kauver AN Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002 28 491 4.
12. Moon SY Chang GY. A complication of cosmetic Surgery. N Engl J Med 2004 350 1549.
13. ®. Approved labeling. (accessed on February 22, 2004).
14. Soparker CNS Patrinely JR Tschen J. Erasing Restylane. Ophthal Plast Reconst Surg 2004 4 317 36.
15. Micheels P. Human anti-hyaluronic acid antibodies is it possible. Dermatol Surg 2001 27 185 91.
16. ®). Contact Dermatitis 2000 43 178 9.
17. Honig JF Brink U Korabiowska MJ. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. Craniofac Surg 2003 14 197 200.
18. Lowe NJ Maxwell CA Lowe PL Duick MG Shah K. Hyaluronic acid skin fillers adverse reactions and skin testing. J Am Acad Dermatol 2001 45 930 3.
19. ® (injectable hyaluronic acid). Plast Reconst Surg 200 106 121 6.
20. Fernandez-Acenero M Zamora A Borbujo J. Granulomatous foreign body reaction against hyaluronic acid report of a case after lip augmentation. Dermatol Surg 2003 29 1225 6.
21. Rongioletti F Cattarini G Sottofattori E Rebora A. Granulomatous reaction after intradermal injection of hyaluronic acid gel. Arch Dermatol 2003 139 815 6.
22. ®): an adverse outcome of lip augmentation. Manuscript, 2005.
23. Andre P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA - Q-Medical Sweden) in European countries a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 2004 18 422 5.
24. Klein AW. Granulomatous foreign body reaction against hyaluronic acid (letter to the editor). Dermatol Surg 2004 30 1071.
25. ®: transcript of an advisory committee meeting for the US Food and Drug Administration (November 21, 2003) (Afternoon Session). (accessed February 22, 2004).
26. Brooks N. A foreign body granuloma produced by an injectable collagen implant at a test site. J Dermatol Surg Oncol 1982 8 111 4.
27. Kim KJ Lee HW Lee MW Choi JH Moon KC Koh JK. Artecoll® granuloma a rare adverse reaction induced by microimplant in the treatment of neck wrinkles. Dermatol Surg 2004 30 545 7.
28. Lombardi T Samson J Plantier F Husson C. Kuffer R. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study in 11 cases. J Oral Pathol Med 2004 33 115 20.
29. Saylan Z. Facial fillers and their complications. Aesthet Surg J 2003 23 221 4.
30. Narins R. Safe liposuction and fat transfer. New York Marcel Dekker 2003.
31. Meyers H Brown-Elliott BA Moore D Curry J Truong C Zhang Y Wallace RJ. Clin Infect Dis 2002 34 1500 7.
32. Fraser V Wallace RJ. Nontuberculous mycobacteria. In Mayhall CG. editor. Hospital epidemiology and infection control. Baltimore Williams & Wilkins 1996 p. 1224 37.
33. Klein JA. Tumescent liposuction: tumescent anesthesia & microcannular liposuction. Mosby 2000 p. 100 1.
34. Centers for Disease Control and Prevention. Rapidly growing mycobacterial infection following liposuction and liposculpture - Caracas, Venezuela, 1996-1998. Morbidity Mortality Weekly Report 1998 47 1065 7.
35. Nolte FS Metchock B. Mycobacterium. In Murray PR editor. Manual of clinical microbiology 6th ed. Washington DC American Society of Microbiology 1995 p. 400 37.
36. Douglas RS Cook T Shorr N. Lumps and bumps late postsurgical inflammatory and infectious lesions. Plast Reconst Surg 2003 112 1923 8.